heiDATA

Metrics

207,636 Downloads

Featured Dataverses

In order to use this feature you must have at least one published dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

Publication Year: 2023

11 to 20 of 2,476 Results

water_tank_detection_model.zip Apr 17, 2023 - Semi-supervised water tank detection to support vector control of emerging infectious diseases transmitted by Aedes Aegpyti [Research Data] ZIP Archive - 266.8 MB - MD5: ed33e5b8f5d600dba36e0f98eaa00b8b water tank detection model SSST_50
water_tank_density.tif Apr 17, 2023 - Semi-supervised water tank detection to support vector control of emerging infectious diseases transmitted by Aedes Aegpyti [Research Data] TIFF Image - 259.8 KB - MD5: 332a4da6142c5a40f4a4c6a56a21fddf 200m water tank count above 90 percent confidence score in raster format with georeferenzed units
waqf-Bibliographie_Archiv.ctv6archive Dec 11, 2023 - Ottoman Waqf Bibliography Unknown - 14.1 MB - MD5: d5f2e3bed89e174d90d75ccdaf45aed3 Citavi
Vardarli_Supplemental Table legends.docx Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data] MS Word - 13.3 KB - MD5: 7c350502f033008bfdfc0f43b17b6199 Supplemental Table legends
Vardarli_Supplemental Figure legends.docx Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data] MS Word - 13.8 KB - MD5: ba86a43da420eaea333e3062bed27e31 Supplemental Figure legends
Vardarli_Suppl. Table 9.pdf Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data] Adobe PDF - 216.7 KB - MD5: 78f6d13d435b94fe3733e03fdaf77c63 Suppl. Table 9. Trim-and-fill results for trials investigating adrenal insufficiency any grade after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials.
Vardarli_Suppl. Table 8.pdf Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data] Adobe PDF - 218.9 KB - MD5: e32fa8cb72081403d574d4d1d280e827 Suppl. Table 8. Trim-and-fill results for trials investigating hypophysitis/hypopituitarism grade 3-5 after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials.
Vardarli_Suppl. Table 7.pdf Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data] Adobe PDF - 216.5 KB - MD5: c1e3211bc08d5e1fd11cb1ca68248762 Suppl. Table 7. Trim-and-fill results for trials investigating hypophysitis/hypopituitarism any grade after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials.
Vardarli_Suppl. Table 6.pdf Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data] Adobe PDF - 220.7 KB - MD5: 30371284a775d08e7044c09b78aaeace Suppl. Table 6. Meta-regression for trials investigating hyperthyroidism any grade after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials.
Vardarli_Suppl. Table 5.pdf Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data] Adobe PDF - 220.6 KB - MD5: 09b0b7b7245dcb116eb15df62fdef98d Suppl. Table 5. Meta-regression for trials investigating hypothyroidism any grade after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials.

water_tank_detection_model.zip

Apr 17, 2023 - Semi-supervised water tank detection to support vector control of emerging infectious diseases transmitted by Aedes Aegpyti [Research Data]

ZIP Archive - 266.8 MB -

water tank detection model SSST_50

water_tank_density.tif

Apr 17, 2023 - Semi-supervised water tank detection to support vector control of emerging infectious diseases transmitted by Aedes Aegpyti [Research Data]

TIFF Image - 259.8 KB -

200m water tank count above 90 percent confidence score in raster format with georeferenzed units

waqf-Bibliographie_Archiv.ctv6archive

Dec 11, 2023 - Ottoman Waqf Bibliography

Unknown - 14.1 MB -

Citavi

Vardarli_Supplemental Table legends.docx

Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data]

MS Word - 13.3 KB -

Supplemental Table legends

Vardarli_Supplemental Figure legends.docx

MS Word - 13.8 KB -

Supplemental Figure legends

Vardarli_Suppl. Table 9.pdf

Adobe PDF - 216.7 KB -

Suppl. Table 9. Trim-and-fill results for trials investigating adrenal insufficiency any grade after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials.

Vardarli_Suppl. Table 8.pdf

Adobe PDF - 218.9 KB -

Suppl. Table 8. Trim-and-fill results for trials investigating hypophysitis/hypopituitarism grade 3-5 after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials.

Vardarli_Suppl. Table 7.pdf

Adobe PDF - 216.5 KB -

Suppl. Table 7. Trim-and-fill results for trials investigating hypophysitis/hypopituitarism any grade after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials.

Vardarli_Suppl. Table 6.pdf

Adobe PDF - 220.7 KB -

Suppl. Table 6. Meta-regression for trials investigating hyperthyroidism any grade after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials.

Vardarli_Suppl. Table 5.pdf

Adobe PDF - 220.6 KB -

Suppl. Table 5. Meta-regression for trials investigating hypothyroidism any grade after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials.

Add Data

Share Dataverse

Link Dataverse

Reset Modifications